Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK's asthma drug Nucala boosted by long-term safety study
GSK's asthma drug Nucala boosted by long-term safety study
GSK's asthma drug Nucala boosted by long-term safety study
Submitted by
admin
on March 7, 2016 - 9:54pm
Source:
BioPharma Dive
News Tags:
GSK
asthma
Nucala
Headline:
GSK's asthma drug Nucala boosted by long-term safety study
Do Not Allow Advertisers to Use My Personal information
